Supreme Court To Hear Matrixx Zicam Securities Case
The U.S. Supreme Court has agreed to take up the question of whether drug companies have to disclose all reports of adverse events linked to a particular drug to shareholders, in...To view the full article, register now.
Already a subscriber? Click here to view full article